Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant tissue-type plasminogen activator derivative vs alteplase in acute ischemic stroke (Phase II)
CTR20190899Phase 2Completed
- Sponsor
- Shandong Ahua Biological Pharmaceutical
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by Shandong Ahua Biological Pharmaceutical. Started May 2019; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20190899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190899.